Viewing data from:

NIACIN

ANDA

NIACIN | A209236 | AUROBINDO PHARMA LTD

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 6 NDCs

Highest NADAC/Unit

$0.3222

per ea

Lowest NADAC/Unit

$0.1696

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
59651002018NIACIN ER 1,000 MG TABLET	$0.3222	EA	Generic	—	2026-08-19
59651002090NIACIN ER 1,000 MG TABLET	$0.3222	EA	Generic	—	2026-08-19
59651001918NIACIN ER 750 MG TABLET	$0.3037	EA	Generic	—	2026-08-19
59651001990NIACIN ER 750 MG TABLET	$0.3037	EA	Generic	—	2026-08-19
59651001818NIACIN ER 500 MG TABLET	$0.1696	EA	Generic	—	2026-08-19
59651001890NIACIN ER 500 MG TABLET	$0.1696	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs4 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

AURORIUM LLCNIACIN USP

DMF 82591989

DIVIS LABORATORIES LTDNIACIN USP

DMF 184812005

AARTI DRUGS LTDNIACIN

DMF 200512006

JUBILANT PHARMOVA LTDNIACIN USP

DMF 313822017

WOCKHARDT LTDInactiveNIACIN

DMF 76421988

LONZA AGInactiveNIACIN USP SPECIAL

DMF 80411989

LONZA LTDInactiveNIACIN USP GRANULAR SPECIAL

DMF 182932005

ABBVIE INCInactiveNIACIN CORE TABLET INTERMEDIATE

DMF 218762008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 500MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Feb 1, 2018

No patent or exclusivity listings for this strength.

#002 — 750MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Feb 1, 2018

#003 — 1GM

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Feb 1, 2018